Sherbrooke Park Advisers LLC Trans Medics Group, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $571 Billion
- Q2 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 3,617 shares of TMDX stock, worth $567,869. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,617
Previous 3,862
6.34%
Holding current value
$567,869
Previous $286 Million
90.78%
% of portfolio
0.1%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding TMDX
# of Institutions
358Shares Held
29.6MCall Options Held
399KPut Options Held
154K-
Black Rock Inc. New York, NY2.65MShares$415 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$397 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$233 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$214 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$180 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $5B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...